Open AccessProceedings Article
Variants in the CDKN2B and RTEL1 regions are associated with high-grade glioma susceptibility
Reads0
Chats0
TLDR
Wrensch et al. as mentioned in this paper found that variants in the CDKN2B and RTEL1 regions are associated with high-grade glioma susceptibility and showed that the direction of association was the same in discovery and replication phases.Abstract:
LETTERS Variants in the CDKN2B and RTEL1 regions are associated with high-grade glioma susceptibility Margaret Wrensch 1,2,12 , Robert B Jenkins 3,12 , Jeffrey S Chang 4,12 , Ru-Fang Yeh 4,12 , Yuanyuan Xiao 4 , Paul A Decker 5 , Karla V Ballman 5 , Mitchel Berger 1 , Jan C Buckner 6 , Susan Chang 1 , Caterina Giannini 3 , Chandralekha Halder 3 , Thomas M Kollmeyer 3 , Matthew L Kosel 5 , Daniel H LaChance 7 , Lucie McCoy 1 , Brian P O’Neill 7 , Joe Patoka 1 , Alexander R Pico 8 , Michael Prados 1 , Charles Quesenberry 9 , Terri Rice 1 , Amanda L Rynearson 3 , Ivan Smirnov 1 , Tarik Tihan 10 , Joe Wiemels 2,4 , Ping Yang 11,13 & John K Wiencke 1,2,13 The causes of glioblastoma and other gliomas remain obscure 1,2 To discover new candidate genes influencing glioma susceptibility, we conducted a principal component– adjusted 3 genome-wide association study (GWAS) of 275,895 autosomal variants among 692 adult high-grade glioma cases (622 from the San Francisco Adult Glioma Study (AGS) and 70 from the Cancer Genome Atlas (TCGA)) 4 and 3,992 controls (602 from AGS and 3,390 from Illumina iControlDB (iControls)) For replication, we analyzed the 13 SNPs with P o 10 A6 using independent data from 176 high-grade glioma cases and 174 controls from the Mayo Clinic On 9p21, rs1412829 near CDKN2B had discovery P ¼ 34 Â 10 A8 , replication P ¼ 00038 and combined P ¼ 185 Â 10 A10 On 20q133, rs6010620 intronic to RTEL1 had discovery P ¼ 15 Â 10 A7 , replication P ¼ 000035 and combined P ¼ 340 Â 10 A9 For both SNPs, the direction of association was the same in discovery and replication phases Subject characteristics, including participation rates for the discovery GWAS and replication phases, are listed in Supplementary Table 1a,b The distribution of P values from the principal component–adjusted logistic regression additive model across the genome for high-grade glioma cases versus controls (Fig 1) suggests potentially meaningful associations for several SNPs on chromosomes 1, 5, 9, 11 and 20 Supplementary Table 2 summarizes results for the 13 SNPs with P o 10 A6 for association with high-grade glioma in discovery data along with results from replication data; SNPs with Hardy-Weinberg P o 10 A5 in controls or with 45% missing data in any case or control group were excluded Three of these 13 SNPs (rs1412829 on 9p21, and rs6010620 and rs4809324 intronic to RTEL1 on 20q133) had significant association with high-grade glioma risk in the discovery phase (principal component analysis P o 18 Â 10 A7 ), were inde- pendent risk predictors in a multivariable analysis of 13 top hits, and were replicated in the Mayo Clinic dataset (Table 1) As shown in Table 1 and Supplementary Table 2, the minor allele frequencies for the three SNPs consistently differed in the same direction between high-grade glioma cases and controls regardless of data source (AGS, TCGA, iControls or Mayo Clinic) Supplementary Table 3 shows results from the multivariable model of discovery data that included all 13 SNPs (four from the 9p21 region, three in RTEL1, plus six others in other locations) Eight SNPs, including one in the 9p21 region and two intronic to RTEL1, remained independently associated with high- grade glioma risk after adjustment for other SNPs This was expected given the strong linkage disequilibrium (LD) evident for the four 9p21 SNPs and two of the three RTEL1 SNPs (Supplementary Table 4) In discovery data, only the interaction between chromosome 9p21 SNP rs1412829 and TERT SNP rs2736100 on chromosome 5 was statistically significant with Wald test P ¼ 0019 (see Supplementary P value Chromosome © 2009 Nature America, Inc All rights reserved Figure 1 Distribution of P values from principal component–adjusted logistic regression additive model across the genome for high-grade glioma cases versus controls The 13 SNPs with P o 10 A6 are shown in red 1 Department of Neurological Surgery, University of California, San Francisco, San Francisco, California, USA 2 Institute of Human Genetics, University of California, San Francisco, San Francisco, California, USA 3 Department of Experimental Pathology, Mayo Clinic, Rochester, Minnesota, USA 4 Department of Epidemiology and Biostatistics, University of California, San Francisco, San Francisco, California, USA 5 Division of Biostatistics, 6 Department of Oncology and 7 Department of Neurology, Mayo Clinic, Rochester, Minnesota, USA 8 Gladstone Institute of Cardiovascular Disease, University of California, San Francisco, San Francisco, California, USA 9 Division of Research, Kaiser Permanente, Oakland, California, USA 10 Department of Pathology, University of California, San Francisco, San Francisco, California, USA 11 Division of Epidemiology, Mayo Clinic, Rochester, Minnesota, USA 12 These authors contributed equally to this work 13 These authors jointly directed the work Correspondence should be addressed to MW (margaretwrensch@ucsfedu) Received 13 March; accepted 1 June; published online 5 July 2009; doi:101038/ng408 NATURE GENETICS ADVANCE ONLINE PUBLICATIONread more
Citations
More filters
Journal ArticleDOI
The epidemiology of glioma in adults: a "state of the science" review.
Quinn T. Ostrom,Luc Bauchet,Faith G. Davis,Isabelle Deltour,James L. Fisher,Chelsea Eastman Langer,Melike Pekmezci,Judith A. Schwartzbaum,Michelle C. Turner,Kyle M. Walsh,Margaret Wrensch,Jill S. Barnholtz-Sloan +11 more
TL;DR: A “state of the science” review of current research into causes and risk factors for gliomas in adults is provided.
Journal ArticleDOI
Glioma Groups Based on 1p/19q, IDH, and TERT Promoter Mutations in Tumors
Jeanette E. Eckel-Passow,Daniel H. Lachance,Annette M. Molinaro,Kyle M. Walsh,Paul A. Decker,Hugues Sicotte,Melike Pekmezci,Terri Rice,Matt L. Kosel,Ivan Smirnov,Gobinda Sarkar,Alissa Caron,Thomas M. Kollmeyer,Corinne Praska,Anisha R. Chada,Chandralekha Halder,Helen M. Hansen,Lucie McCoy,Paige M. Bracci,Roxanne Marshall,Shichun Zheng,Gerald F. Reis,Alexander R. Pico,Brian P. O'Neill,Jan C. Buckner,Caterina Giannini,Jason T. Huse,Arie Perry,Tarik Tihan,Mitchell S. Berger,Susan M. Chang,Michael D. Prados,Joseph L. Wiemels,John K. Wiencke,Margaret Wrensch,Robert B. Jenkins +35 more
TL;DR: The five glioma molecular groups had different ages at onset, overall survival, and associations with germline variants, which implies that they are characterized by distinct mechanisms of pathogenesis.
Journal ArticleDOI
Epidemiologic and Molecular Prognostic Review of Glioblastoma
Jigisha P. Thakkar,Therese A. Dolecek,Craig Horbinski,Quinn T. Ostrom,Donita Lightner,Jill S. Barnholtz-Sloan,John L. Villano +6 more
TL;DR: The current epidemiology of GBM is reported with new data from the Central Brain Tumor Registry of the United States 2006 to 2010 as well as demonstrate and discuss trends in incidence and survival.
Journal ArticleDOI
Expression of Linear and Novel Circular Forms of an INK4/ARF-Associated Non-Coding RNA Correlates with Atherosclerosis Risk
TL;DR: The results identify novel circular RNA products emanating from the ANRIL locus and suggest causal variants at 9p21.3 regulate INK4/ARF expression and ASVD risk by modulating ANRil expression and/or structure.
Journal ArticleDOI
Genetics of adult glioma
TL;DR: The discovery of two separate molecular subtypes within the glioma classification that appear to correlate with biological etiology, prognosis, and response to therapy suggests that molecular genetic tests are and will be useful, beyond classical histology, for the clinical classification of gliomas.
References
More filters
Journal ArticleDOI
Diffuse gliomas classified by 1p/19q co-deletion, TERT promoter and IDH mutation status are associated with specific genetic risk loci
Karim Labreche,Karim Labreche,Ben Kinnersley,Giulia Berzero,Giulia Berzero,Anna Luisa Di Stefano,Amithys Rahimian,Ines Detrait,Yannick Marie,Benjamin Grenier-Boley,Khê Hoang-Xuan,Jean-Yves Delattre,Ahmed Idbaih,Richard S. Houlston,Marc Sanson +14 more
TL;DR: To link risk SNPs to target candidate genes the authors analysed Hi-C and gene expression data, highlighting the potential role of IDH1 at 2q33.33 and STMN3 at 20q13.21 to provide further insight into the nature of susceptibility to glioma.
Journal ArticleDOI
Telomere structure and maintenance gene variants and risk of five cancer types
Sara Karami,Younghun Han,Mala Pande,Iona Cheng,James Rudd,Brandon L. Pierce,Ellen L. Nutter,Fredrick R. Schumacher,Zsofia Kote-Jarai,Sara Lindström,John S. Witte,Shenying Fang,Jiali Han,Peter Kraft,David J. Hunter,Fengju Song,Rayjean J. Hung,James McKay,Stephen B. Gruber,Stephen J. Chanock,Angela Risch,Hongbing Shen,Christopher A. Haiman,Lisa A. Boardman,Cornelia M. Ulrich,Cornelia M. Ulrich,Graham Casey,Ulrike Peters,Ali Amin Al Olama,Andrew Berchuck,Sonja I. Berndt,Stéphane Bézieau,Paul Brennan,Hermann Brenner,Louise A. Brinton,Neil E. Caporaso,Andrew T. Chan,Andrew T. Chan,Jenny Chang-Claude,David C. Christiani,Julie M. Cunningham,Douglas F. Easton,Rosalind A. Eeles,Timothy Eisen,Manish Gala,Steven Gallinger,Simon A. Gayther,Ellen L. Goode,Henrik Grönberg,Brian E. Henderson,Richard S. Houlston,Amit Joshi,Sébastien Küry,Mari T. Landi,Loic Le Marchand,Kenneth Muir,Kenneth Muir,Polly A. Newcomb,Jenny Permuth-Wey,Paul D.P. Pharoah,Catherine M. Phelan,John D. Potter,Susan J. Ramus,Harvey A. Risch,Joellen M. Schildkraut,Martha L. Slattery,Honglin Song,Nicolas Wentzensen,Emily White,Fredrik Wiklund,Brent W. Zanke,Thomas A. Sellers,Wei Zheng,Nilanjan Chatterjee,Christopher I. Amos,Jennifer A. Doherty,Tricl +76 more
TL;DR: Ass associations between variants in 22 telomere structure and maintenance gene regions and colorectal, breast, prostate, ovarian, and lung cancer risk are investigated to provide insight into mechanisms through which telomeres dysfunction in different tissues influences cancer risk.
Journal ArticleDOI
Trends and patterns of incidence of diffuse glioma in adults in the United States, 1973‐2014
TL;DR: The objective of the study was to identify trends in incidence of adult diffuse gliomas in the United States and evaluate the contribution of age, period, and cohort effects to the trends.
Journal ArticleDOI
Quantifying the heritability of glioma using genome-wide complex trait analysis.
Ben Kinnersley,Jonathan S. Mitchell,Konstantinos Gousias,Johannes Schramm,Ahmed Idbaih,Marianne Labussière,Yannick Marie,Amithys Rahimian,H.-Erich Wichmann,H.-Erich Wichmann,Stefan Schreiber,Khê Hoang-Xuan,Jean-Yves Delattre,Markus M. Nöthen,Karima Mokhtari,Mark Lathrop,Mark Lathrop,Melissa L. Bondy,Matthias Simon,Marc Sanson,Richard S. Houlston +20 more
TL;DR: GCTA was applied to three GWAS datasets totalling 3,373 cases and 4,571 controls and performed a meta-analysis to estimate the heritability of glioma, indicating that most of the heritable risk attributable to common genetic variants remains to be identified.
Journal ArticleDOI
11q13 is a susceptibility locus for hormone receptor positive breast cancer
Diether Lambrechts,Thérèse Truong,Christina Justenhoven,Manjeet K. Humphreys,Jean Wang,John L. Hopper,Gillian S. Dite,Carmel Apicella,MC Southey,Marjanka K. Schmidt,Annegien Broeks,Sten Cornelissen,Richard van Hien,Elinor J. Sawyer,Ian Tomlinson,Michael J. Kerin,Nicola Miller,Roger L. Milne,M. Pilar Zamora,Jose Ignacio Arias Perez,Javier Benitez,Ute Hamann,Yon Ko,Thomas Brüning,Jenny Chang-Claude,Ursel Eilber,Rebecca Hein,Stefan Nickels,Dieter Flesch-Janys,Shan Wang-Gohrke,Esther M. John,Alexander Miron,Robert Winqvist,Katri Pylkäs,Arja Jukkola-Vuorinen,Mervi Grip,Georgia Chenevix-Trench,Jonathan Beesley,Xiaoqing Chen,kConFab Investigators,Florence Menegaux,Emilie Cordina-Duverger,Chen-Yang Shen,Jyh Cherng Yu,Pei Ei Wu,Ming-Feng Hou,Irene L. Andrulis,Teresa Selander,Gord Glendon,Anna Marie Mulligan,Hoda Anton-Culver,Argyrios Ziogas,Kenneth Muir,Artitaya Lophatananon,Suthee Rattanamongkongul,Puttisak Puttawibul,Michael Jones,Nick Orr,Alan Ashworth,Anthony J. Swerdlow,Gianluca Severi,Laura Baglietto,Graham G. Giles,Graham G. Giles,Melissa C. Southey,Federik Marme,Andreas Schneeweiss,Christof Sohn,Barbara Burwinkel,Barbara Burwinkel,Betül T. Yesilyurt,Patrick Neven,Robert Paridaens,Hans Wildiers,Hermann Brenner,Heiko Müller,Volker Arndt,Christa Stegmaier,Alfons Meindl,Sarah Schott,Claus R. Bartram,Rita K. Schmutzler,Angela Cox,Ian W. Brock,Graeme Elliott,Simon S. Cross,Peter A. Fasching,Ruediger Schulz-Wendtland,Arif B. Ekici,Matthias W. Beckmann,Olivia Fletcher,Nichola Johnson,Isabel dos Santos Silva,Julian Peto,Heli Nevanlinna,Taru A. Muranen,Kristiina Aittomäki,Carl Blomqvist,Thilo Dörk,Peter Schürmann,Michael Bremer,Peter Hillemanns,Natalia Bogdanova,Natalia Antonenkova,Yuri I. Rogov,Johann H. Karstens,Elza Khusnutdinova,Marina Bermisheva,Darya Prokofieva,Shamil Gancev,Anna Jakubowska,Jan Lubinski,Katarzyna Jaworska,Katarzyna Durda,Børge G. Nordestgaard,Stig E. Bojesen,Charlotte Lanng,Arto Mannermaa,Vesa Kataja,Veli-Matti Kosma,Jaana M. Hartikainen,Paolo Radice,Paolo Peterlongo,Siranoush Manoukian,Loris Bernard,Fergus J. Couch,Janet E. Olson,Xianshu Wang,Zachary S. Fredericksen,Grethe I. Grenaker Alnæs,Vessela N. Kristensen,Vessela N. Kristensen,Anne Lise Børresen-Dale,Anne Lise Børresen-Dale,Peter Devilee,Robert A.E.M. Tollenaar,Caroline M. Seynaeve,Maartje J. Hooning,Montserrat Garcia-Closas,Stephen J. Chanock,Jolanta Lissowska,Mark E. Sherman,Per Hall,Jianjun Liu,Kamila Czene,Daehee Kang,Keun-Young Yoo,Dong Young Noh,Annika Lindblom,Sara Margolin,Alison M. Dunning,Paul D.P. Pharoah,Douglas F. Easton,Pascal Guénel,Hiltrud Brauch,Hiltrud Brauch +155 more
TL;DR: The strongest evidence was obtained for rs614367, located on 11q13, which was specific to estrogen receptor (ER)‐positive disease and strongest for ER plus progesterone receptor (PR)‐ positive breast cancer, whereas the associations for the other three loci did not differ by tumor subtype.
Related Papers (5)
Abstract B11: Replication of previously identified breast cancer susceptibility loci in a breast cancer case-control study on women of African ancestry
Yonglan Zheng,Dezheng Huo,Temidayo O. Ogundiran,Adeyinka G. Falusi,Oladosu Ojengbede,Clement Adebamowo,William J. Blot,Wei Zheng,Qiuyin Cai,Lisa B. Signorello,Katherine L. Nathanson,Susan M. Domchek,Timothy R. Rebbeck,Michael S. Simon,Anselm Hennis,Barbara Nemesure,Suh-Yuh Wu,M.C. Leske,Stefan Ambs,Abayomi Odetunde,Imaria Anetor,Stella Akinleye,Qun Niu,Jing Zhang,Anna Pluzhnikov,Anuar Konkashbaev,Lin Chen,Eric R. Gamazon,Younghee Lee,Nancy J. Cox,Olufunmilayo O. Olopade +30 more
Abstract LB-299: Genome wide association study of breast cancer in Latinas identifies protective variants of Indigenous American origin on 6q25
Laura Fejerman,Nasim Ahmadiyeh,Donglei Hu,Scott Huntsman,Kenneth B. Beckman,Jennifer L. Caswell,Esther M. John,Gabriela Torres-Mejía,Luis G. Carvajal-Carmona,Magdalena Echeverry,Anna Marie Tuazon,Carolina Ramirez,Christopher R. Gignoux,Celeste Eng,Esteban Gonzalez-Burchard,Brian E. Henderson,Loic Le Marchand,Eliseo J. Pérez-Stable,Christopher A. Haiman,Elad Ziv +19 more